CLOMIPRAMINE Drug Patent Profile

When do Clomipramine patents expire, and what generic alternatives are available?

Clomipramine is a drug marketed by Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chartwell Rx, Jubilant Cadista, Leading, Lupin, Mankind Pharma, Micro Labs, Pharmobedient, Rk Pharma, Sandoz, Taro, Teva, Tp Anda Holdings, Unique, Watson Labs, and Zydus Pharms. and is included in twenty-one NDAs.

The generic ingredient in CLOMIPRAMINE is clomipramine hydrochloride. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Clomipramine

A generic version of CLOMIPRAMINE was approved as clomipramine hydrochloride by CHARTWELL RX on March 29^th, 1996.

Summary for CLOMIPRAMINE

US Patents:	0
Applicants:	19
NDAs:	21
Drug Prices:	Drug price information for CLOMIPRAMINE
DailyMed Link:	CLOMIPRAMINE at DailyMed

See drug prices for CLOMIPRAMINE

US Patents and Regulatory Information for CLOMIPRAMINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074694-002	Dec 31, 1996	AB	RX	No	No
Pharmobedient	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074947-002	Apr 30, 1998		DISCN	No	No
Tp Anda Holdings	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	210653-001	Apr 3, 2020		DISCN	No	No
Watson Labs	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074751-003	Sep 30, 1998		DISCN	No	No
Teva	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	074849-002	Apr 4, 1997		DISCN	No	No
Tp Anda Holdings	CLOMIPRAMINE HYDROCHLORIDE	clomipramine hydrochloride	CAPSULE;ORAL	210653-002	Apr 3, 2020		DISCN	No	No

DrugChatter Q&A for CLOMIPRAMINE

Clomipramine tablet uses?